Want to create an interactive transcript for this episode?
Podcast: OncLive® On Air
Episode: Khouri Highlights the Ongoing AFFIRM-AL Trial in AL Amyloidosis
Description: Dr Khouri discusses unmet needs in AL amyloidosis, the potential for birtamimab to become a new frontline standard of care beyond daratumumab, and the importance of confirming earlier post-hoc results from the placebo-controlled phase 3 VITAL trial in the ongoing AFFIRM-AL trial in patients with Mayo stage IV AL amyloidosis with cardiac involvement.